A novel model based on qAnti-HBc and conventional biomarkers for identifying significant liver injury among CHB patients with ALT <= ULN

Feng, MY; Liu, KH; Zhao, GD; Lou, SK; An, BY; Lin, LY; Ding, YZ; Bao, SS; Wang, H

Ding, YZ; Bao, SS; Wang, H (通讯作者)，Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Infect Dis, Shanghai 200025, Peoples R China.

ANTIVIRAL RESEARCH, 2022; 202 ():

Abstract

Background: Antiviral therapy is not routinely recommended for CHB patients with ALT &lt;= ULN (CHB-NALT), based on current international guidelines. ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索